4Boillot O, Baulieux J, Wolf P, et al. Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation. Clin Transplant ,2001,15 (3) : 159-166.
5Matinlauri IH, Nurminen MM, Hockerstedt KA, et al. Changes in Liver Graft Rejections Over Time. Transplant Proc, 2006,38 ( 8 ) : 2663 -2666.
6Chikashi N, Naoki N, Satoshi S, et al. Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature. Tohoku J Exp Med,2007,211 (2) :195-200.
7David W, Portmann B, Knisely A, et al. Anti-Interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid- resistant rejection in adult liver transplantation. Transplant Proc, 2005,37(10) :4373-4379.
8Bullingham RE, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil ( RS61443 ) :A short review [J]. Transplant Proc, 1996,28(2) :925-928.
9Johnston A, David OJ, Cooney GF. Pharmacokinetic validation of neural absorption profiling[J]. Transplant Proc,2000,32(Suppl 3A) :53.
10Mark AL, Anclrea D. Immunosupression after adult renal transplant[J]. Pharmaceutical J,2001,266:754.
